Interestingly, an inverse CCL20+/CCR6+ ‘immunoscore’ profile was observed in the CC group, when compared to CIN I (χ2 = 16.54, p = 0.002), CIN II (χ2 = 6.02, p = 0.049) and CIN III (χ2 = 12.09, p = 0.01) (Fig. 6B). The gene discussed is CCR6; the disease is uterine cervix carcinoma in situ.